As the AI in pathology market expected to reach $1,151.55 million by 2033, innovators such as Kameda Medical Center utilize these high-value digital workflows to combat critical global labor shortages.
Can a global healthcare system survive when the demand for life-saving diagnostics far outpaces the number of doctors available to perform them? This question sits at the heart of a growing crisis in modern medicine. Pathologists are the hidden engines of the healthcare world, providing the definitive diagnoses required for cancer treatment and chronic disease management. However, the profession is currently facing a severe labor shortage. As seasoned experts retire and fewer students enter the field, the industry is forced to look toward technology for a sustainable solution.
The AI in pathology market represents the primary answer to this challenge. Estimated to reach $1,151.55 million by 2033, this sector provides the digital infrastructure necessary to augment a shrinking workforce. The goal is no longer to replace human expertise but to provide a digital assistant that can manage the overwhelming volume of data generated in a modern laboratory. This shift marks the end of the era of the isolated microscope and the beginning of the integrated, AI-enhanced diagnostic suite.
Why the Lab is Hitting a Breaking Point
Traditional pathology relies on the physical examination of tissue samples on glass slides. This process is inherently slow and prone to the limitations of human endurance. A pathologist must manually scan every millimeter of a slide to identify minute clusters of malignant cells. This task requires intense concentration, and over the course of a long shift, fatigue can lead to decreased efficiency.
The math of the current labor market is unsustainable. An aging global population requires more biopsies and increasingly complex testing, yet the number of qualified pathologists is not growing fast enough to meet the need. This imbalance creates a bottleneck that results in longer wait times for patients and increased pressure on existing staff. AI helps resolve this by acting as a first-read support system, flagging suspicious areas so that the specialist can focus on the most critical elements of a case.
From Glass Slides to Global Collaboration
A major hurdle in the traditional laboratory is the physical nature of the evidence. If a second opinion is required from a specialist in another city, the glass slide must be physically shipped. This introduces delays and the risk of damage to the sample. Digital pathology removes these physical barriers by converting tissue samples into high-resolution digital files that can be shared instantly across the globe.
Once a laboratory transitions to a digital format, AI can be integrated directly into the workflow. The software can pre-calculate tumor margins and sort cases based on clinical urgency. Instead of starting the day with a random stack of slides, a pathologist can begin with a prioritized list where the most complex or time-sensitive cases are already highlighted.
Learning from the Leaders: Kameda Medical Center
The practical benefits of this technology are evident in the recent digital transformation at Kameda Medical Center. As a private medical group in Japan, Kameda Medical Center has started implementing a digital pathology system, in January 2026, as part of its transition to a new enterprise pathology platform.
The new AI-integrated system, provided by the Swedish medical technology company Sectra, will digitize pathology workflows. This allows pathologists to review and collaborate on cases using digital images of tissue samples. The platform provides remote access to digital images, which reduces the reliance on physical glass slides and microscope-only review. This implementation follows a contract signed between Kameda and Sectra last year. It builds on the Japanese hospital’s almost decade-long experience operating as a fully digital pathology laboratory. This move demonstrates how even experienced digital labs are now integrating AI to further streamline their operations and manage heavy workloads.
AI as a Tool for Triage and Consistency
The most significant impact of AI in the laboratory is its ability to perform the repetitive, quantitative tasks that consume a large portion of a doctor’s time. Routine, low-complexity cases often make up the bulk of the daily volume. AI can screen these samples with high speed and consistency, allowing the human expert to dedicate more time to nuanced and rare cases that require advanced clinical judgment.
Computers do not experience the fatigue or ‘screen blindness’ that can affect a human after hours of repetitive work. A digital assistant views every cell with the same level of precision, regardless of the time of day. By automating the counting of biomarkers and the measurement of tumor cells, AI ensures that the pathologist remains a consultant and a diagnostician rather than a manual counter.
Creating a Sustainable Future for Pathology
The emergence of the digital assistant is not a threat to the profession but a necessary evolution. By removing the burden of repetitive tasks, AI allows pathologists to work at the highest level of their clinical training. This technological leap also makes the field more appealing to new medical professionals who expect to work with modern, data-driven tools. As the AI in pathology market continues to grow, more institutions will likely adopt the model seen at Kameda Medical Center. Moving toward an AI-augmented workflow is the most viable path to solving the labor crisis. It ensures that diagnostic accuracy remains high and that patient care is not compromised by a shortage of human staff. The integration of these smart systems ensures that the future of pathology is both more efficient and more resilient.
